What are the recent financial highlights of VAISHALI PHARMA LIMITED?

VAISHALI PHARMA LIMITED recently reported a total revenue of ₹99.18 Cr and a net profit margin of 0.43%. These metrics reflect the company’s consistent financial performance.

What are the key financial metrics of VAISHALI PHARMA LIMITED?

Key financial metrics include a trailing P/E ratio of 215.0, forward P/E of , book value of ₹5.199, price-to-book ratio of 2.4812465, and a market capitalization of ₹1.68 billion.

What does VAISHALI PHARMA LIMITED do?

Vaishali Pharma Limited engages in the pharmaceutical business in India and internationally. It offers active pharmaceutical ingredients (APIs), including antibiotics, anti-ulcer, anti-inflammatory/analgesic/anti-pyretic, anti-malarial, cardiac, anti-diabetic, anti-cold/anti-allergic, anti-diarrheal/anti-protozoal/anti-parasitic, anti-viral, anti-epileptic, anti-asthmatic, anti-fungal, anti-platelet agent, skeletal muscle relaxant, and anti-helmintic drugs, as well as excipients, topical steroids, corticosteroids, and enzymes. The company also provides formulation products, such as antibiotics/antibacterial, anti platelet, laxative, anti-ulcer/enzyme, anti-asthmatic, anti malarial, anti-cold/anti-allergic/anti-viral, anti-psychotic, cardiac, anti-diabetic, anti-inflamatory/ananlgesic/anti-pyretic, topical steroids/corticosteroids, anti-fungal, vitamins, and other formulations. In addition, it offers veterinary, nutraceutical, oncology, herbal, and surgical products. The company was formerly known as Vaishali Pharma Private Limited. Vaishali Pharma Limited was founded in 1989 and is based in Mumbai, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Vaishali

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Vaishali

Latest updates related to Vaishali

Sr No.	Title	Sentiment
1	Buy or sell: Vaishali Parekh recommends three stocks to buy today — February 19 Mint	🔄
2	Buy or sell: Vaishali Parekh recommends three stocks to buy today — December 18 Mint	🔄
3	Buy or sell: Vaishali Parekh recommends three stocks to buy today — June 6 Mint	🔄
4	Buy or sell: Vaishali Parekh recommends three stocks to buy today — February 20 Mint	🔄
5	Buy or sell: Vaishali Parekh recommends three stocks to buy today — Nov 5 Mint	🔄
6	Buy or sell: Vaishali Parekh recommends three stocks to buy today — October 16 Mint	🔄
7	Buy or sell: Vaishali Parekh recommends 3 stocks to buy today — February 17 Mint	🔄
8	Stock Radar: Time to buy? GSFC stock consolidating near 180-200 zone, says Vaishali Parekh The Economic Times	🔄
9	Buy or sell: Vaishali Parekh recommends three stocks for today — December 11 Mint	🔄
10	Buy or sell: Vaishali Parekh recommends three stocks to buy today — December 15 Mint	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

EUROTEXIND S&SPOWER SANDUMA MANAKSIA DEEPINDS KAUSHALYA GUJAPOLLO PRINCEPIPE GANGAFORGE BBTCL